Clinical Chemistry

Article	Citations
Inflammation in Atherosclerosis—No Longer a Theory	180
Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation	152
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease	148
Lipoprotein(a) and Cardiovascular Disease	127
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Cl	89
The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis	81
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease	67
Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections	67
Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test	62
Clinical Impact of the Refit CKD-EPI 2021 Creatinine-Based eGFR Equation	59
Lateral Flow Assays in Infectious Disease Diagnosis	58
Myocardial Injury and the Release of Troponins I and T in the Blood of Patients	56
Personalized Reference Intervals in Laboratory Medicine: A New Model Based on Within-Subject Biological Variation	55
Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaborati	53
Efficiency Correction Is Required for Accurate Quantitative PCR Analysis and Reporting	52
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test	50
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis	48
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer	46
The Dangers of Using Cq to Quantify Nucleic Acid in Biological Samples: A Lesson From COVID-19	44
Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance	42
Development of an LC-MS/MS Proposed Candidate Reference Method for the Standardization of Analytical Methods to Measure Lipoprotein(a)	40
Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection	40
Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application o	39
SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19	39
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study	37

Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study	37
Evolving Applications of Artificial Intelligence and Machine Learning in Infectious Diseases Testing	35
Verification of Harmonization of Serum Total and Free Prostate-Specific Antigen (PSA) Measurements and Implications for Medical Decisions	34
Forever Connected: The Lifelong Biological Consequences of Fetomaternal and Maternofetal Microchimerism	34
Artificial Intelligence and Mapping a New Direction in Laboratory Medicine: A Review	33
Assessing the Accuracy and Clinical Utility of ChatGPT in Laboratory Medicine	32
Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues	32
Performance of a Paired-End Sequencing-Based Noninvasive Prenatal Screening Test in the Detection of Genome-Wide Fetal Chromosomal Anomalies	32
Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients	32
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population	31
Cell-Free DNA as Biomarker for Sepsis by Integration of Microbial and Host Information	31
Comprehensive Analysis of Congenital Adrenal Hyperplasia Using Long-Read Sequencing	30
Elementary Overview of Heavy Metals	30
Characteristics of Fetal Extrachromosomal Circular DNA in Maternal Plasma: Methylation Status and Clearance	30
Standardized Workflow for Precise Mid- and High-Throughput Proteomics of Blood Biofluids	30
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow	30
High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19	30
Jagged Ends of Urinary Cell-Free DNA: Characterization and Feasibility Assessment in Bladder Cancer Detection	29
Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals	29
Serum Prostate-Specific Antigen Testing for Early Detection of Prostate Cancer: Managing the Gap between Clinical and Laboratory Practice	29
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID	28
Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples	28
The Truth about SARS-CoV-2 Cycle Threshold Values Is Rarely Pure and Never Simple	27
Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP	27
A Highly Automated Mobile Laboratory for On-site Molecular Diagnostics in the COVID-19 Pandemic	27
Getting Cardiac Troponin Right: Appraisal of the 2020 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elev	27
Implementation of High-Sensitivity and Point-of-Care Cardiac Troponin Assays into Practice: Some Different Thoughts	26
Digital Microfluidic Hemagglutination Assays for Blood Typing, Donor Compatibility Testing, and Hematocrit Analysis	26
Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study	26
Nanopore Identification of Single Nucleotide Mutations in Circulating Tumor DNA by Multiplexed Ligation	26
Plasma Glial Fibrillary Acidic Protein in the Alzheimer Disease Continuum: Relationship to Other Biomarkers, Differential Diagnosis, and Prediction of Clinical Progression	25
Current State of Laboratory Automation in Clinical Microbiology Laboratory	25
Development of a Plasma Biomarker Diagnostic Model Incorporating Ultrasensitive Digital Immunoassay as a Screening Strategy for Alzheimer Disease in a Chinese Population	25
Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients	24
Diagnostic Performance of Metagenomic Next-Generation Sequencing in Pediatric Patients: A Retrospective Study in a Large Children’s Medical Center	24
Metabolomics in Clinical Practice: Improving Diagnosis and Informing Management	23
RIbench: A Proposed Benchmark for the Standardized Evaluation of Indirect Methods for Reference Interval Estimation	23
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers	23
Biological Variation of Cardiac Troponins in Health and Disease: A Systematic Review and Meta-analysis	23
How Can We Ensure Reproducibility and Clinical Translation of Machine Learning Applications in Laboratory Medicine?	23
The Vitamin D Metabolite Ratio Is Independent of Vitamin D Binding Protein Concentration	23
Glycated Albumin for the Diagnosis of Diabetes in US Adults	22
Analytical Sensitivity and Specificity of Four Point of Care Rapid Antigen Diagnostic Tests for SARS-CoV-2 Using Real-Time Quantitative PCR, Quantitative Droplet Digital PCR, and a Mass Spectrometric	22
Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma	22
Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study	22
SwabExpress: An End-to-End Protocol for Extraction-Free COVID-19 Testing	22
AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories	21
Regression-Adjusted Real-Time Quality Control	21
HDL in Morbidity and Mortality: A 40+ Year Perspective	21
Single-Cell Identification, Drug Susceptibility Test, and Whole-genome Sequencing of Helicobacter pylori Directly from Gastric Biopsy by Clinical Antimicrobial Susceptibility Test Ramanometry	21

Circular RNA Sequencing Reveals Serum Exosome Circular RNA Panel for High-Grade Astrocytoma Diagnosis	20
Recent Advances in Rapid Antimicrobial Susceptibility Testing	20
Very Low-Density Lipoprotein Cholesterol May Mediate a Substantial Component of the Effect of Obesity on Myocardial Infarction Risk: The Copenhagen General Population Study	20
The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation	20
Type 2 Myocardial Infarction: Evolving Approaches to Diagnosis and Risk-Stratification	20
Whole-Transcriptome Analysis by RNA Sequencing for Genetic Diagnosis of Mendelian Skin Disorders in the Context of Consanguinity	19
Biomarkers for Risk Assessment in Atrial Fibrillation	19
Cardiac Troponin Testing in Patients with COVID-19: A Strategy for Testing and Reporting Results	19
Urinary Metabolite Biomarkers for the Detection of Synthetic Cannabinoid ADB-BUTINACA Abuse	19
Harmonization of LC-MS/MS Measurements of Plasma Free Normetanephrine, Metanephrine, and 3-Methoxytyramine	19
Cell-Free DNA Fragmentomics: The New “Omics” on the Block	19
Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome	18
Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure	18
Validation of an LC-MS/MS Method Using Solid-Phase Extraction for the Quantification of 1-84 Parathyroid Hormone: Toward a Candidate Reference Measurement Procedure	18
Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review	18
Machine Learning in Laboratory Medicine: Recommendations of the IFCC Working Group	18
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid	17
Multiplex PCR and Nanopore Sequencing of Genes Associated with Antimicrobial Resistance in Neisseria gonorrhoeae Directly from Clinical Samples	16
Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM)	16
ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease	16
Glycated Albumin and Risk of Mortality in the US Adult Population	16
Breath Metabolites to Diagnose Infection	16
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure	16
Achieving Expert-Level Interpretation of Serum Protein Electrophoresis through Deep Learning Driven by Human Reasoning	16
Biomarkers and Clinical Laboratory Detection of Acute and Chronic Ethanol Use	16
Deep Convolutional Neural Networks Implementation for the Analysis of Urine Culture	16
Interoperability: COVID-19 as an Impetus for Change	16
Comprehensive Analysis of Fragile X Syndrome: Full Characterization of the FMR1 Locus by Long-Read Sequencing	16
Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests	16
The European Biological Variation Study (EuBIVAS): Biological Variation Data for Coagulation Markers Estimated by a Bayesian Model	16
A Collaborative Effort to Define Classification Criteria forATMVariants in Hereditary Cancer Patients	16
Interpreting EQA—Understanding Why Commutability of Materials Matters	16
Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management	16
Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay forPD-L1Transcripts in Circulating Tumor Cells	16
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer	15
Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer	15
Evaluation of Sperm DNA Integrity by Mean Number of Sperm DNA Breaks Rather Than Sperm DNA Fragmentation Index	15
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study	15
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus	15
Clinical Translation and Evaluation of a Handheld and Biocompatible Mass Spectrometry Probe for Surgical Use	15
Harmonization Status of Serum Ferritin Measurements and Implications for Use as Marker of Iron-Related Disorders	15
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring	15
Cardiac Biomarkers in Pediatrics: An Undervalued Resource	15
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational Burden	15
High-Throughput CRISPR–Cas13 SARS-CoV-2 Test	15
Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly	14
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)	14
A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making	14
Evaluating the Clinical Utility of a Long-Read Sequencing-Based Approach in Prenatal Diagnosis of Thalassemia	14
Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer	14
Early Rule-Out Strategies in the Emergency Department Utilizing High-Sensitivity Cardiac Troponin Assays	14
Long-Term Longitudinal Stability of Kidney Filtration Marker Measurements: Implications for Epidemiological Studies and Clinical Care	14
Sex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women	13
Dutch National Round Robin Trial on Plasma-Derived Circulating Cell-Free DNA Extraction Methods Routinely Used in Clinical Pathology for Molecular Tumor Profiling	13
Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes	13
Epidemiology of Cancer	13
Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test	13
Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis	13
Laboratory-Developed Tests in the New European Union 2017/746 Regulation: Opportunities and Risks	13
Identifying Clinically Relevant Bacteria Directly from Culture and Clinical Samples with a Handheld Mass Spectrometry Probe	13
Clinical Decision Support for Laboratory Testing	13
Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients	13
Diagnostic Stewardship in Clinical Microbiology, Essential Partner to Antimicrobial Stewardship	13
Neutral-Coating Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Top-Down Identification of Hemoglobin Variants	13
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study	13
Digital Quantification of Chemical Oligonucleotide Synthesis Errors	12
Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection	12
Data Mining Approaches to Reference Interval Studies	12
Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study	12
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells—The DETECT III Clinical Trial	12
Plasma Concentrations of Magnesium and Risk of Dementia: A General Population Study of 102 648 Individuals	12
An Update on Laboratory-Based Diagnostic Biomarkers for Multiple Sclerosis and Beyond	12
TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability	12
Expert-Level Immunofixation Electrophoresis Image Recognition based on Explainable and Generalizable Deep Learning	12
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma	12
Limited Evidence for Use of a Black Race Modifier in eGFR Calculations: A Systematic Review	12
LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial	12
Guidance on Which Calibrators in a Metrologically Traceable Calibration Hierarchy Must Be Commutable with Clinical Samples	12
Commutability Assessment of Candidate Reference Materials for Lipoprotein(a) by Comparison of a MS-based Candidate Reference Measurement Procedure with Immunoassays	11
Diagnostic Validation of a High-Sensitivity Cardiac Troponin I Assay	11

Molecular Diagnosis of Pneumonia (Including Multiplex Panels)	11
Sex-Specific Kinetics of High-Sensitivity Cardiac Troponin I and T following Symptom Onset and Early Presentation in Non-ST-Segment Elevation Myocardial Infarction	11
Error Characterization and Statistical Modeling Improves Circulating Tumor DNA Detection by Droplet Digital PCR	11
Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma	11
Multiplex Fragment Analysis for Flexible Detection of All SARS-CoV-2 Variants of Concern	11
Use of Racial and Ethnic Categories in Medical Testing and Diagnosis: Primum Non Nocere	11
Effect of Macrotroponin in a Cohort of Community Patients with Elevated Cardiac Troponin	11
Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries	11
How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Labo	11
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial	11
Relative Efficacy of Different Strategies for Inhibition of in Vitro Glycolysis	11
Multiplex Detection of Clinically Relevant Mutations in Liquid Biopsies of Cancer Patients Using a Hybridization-Based Platform	11
Metabolomic Fingerprints in Large Population Cohorts: Impact of Preanalytical Heterogeneity	10
Measurement of Immature Reticulocytes in Dried Blood Spots by Mass Spectrometry	10
At-Home Testing for Infectious Diseases: The Laboratory Where You Live	10
A Multicancer Malignant Pleural Effusion Diagnostic Test Using Hexokinase 2 and Single-Cell Sequencing	10
Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma	10
Uncertainty in Estimated Glomerular Filtration Rate Is Much Larger than the Race Adjustment Term	10
Functional Assessment of Vitamin D Status by a Novel Metabolic Approach: The Low Vitamin D Profile Concept	10
Diabetes Duration and Subclinical Myocardial Injury: The Atherosclerosis Risk in Communities Study (ARIC)	10
Update on Serum Biomarkers in Autoimmune Atrophic Gastritis	10
Plasma Clearance of B-Type Natriuretic Peptide (BNP) before and after Bariatric Surgery for Morbid Obesity	10
Angiogenic Biomarkers for Risk Stratification in Women with Preeclampsia	10
AI Chatbots in Clinical Laboratory Medicine: Foundations and Trends	10
The Present and Future of Lipid Testing in Cardiovascular Risk Assessment	10
Optimized Droplet Digital PCR Assay on Cell-Free DNA Samples for Non-Invasive Prenatal Diagnosis: Application to Beta-Thalassemia	10
High-Sensitivity Single Molecule Array Assays for Pathological Isoforms in Parkinson’s Disease	10
Direct Water-Assisted Laser Desorption/Ionization Mass Spectrometry Lipidomic Analysis and Classification of Formalin-Fixed Paraffin-Embedded Sarcoma Tissues without Dewaxing	10
Next-Generation Sequencing–Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients	9
Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment	9
Microbial Taxonomy: How and Why Name Changes Occur and Their Significance for (Clinical) Microbiology	9
Should LC-MS/MS Be the Reference Measurement Procedure to Determine Protein Concentrations in Human Samples?	9
Perspective on New Equations for Estimating Glomerular Filtration Rate	9
Improving Harmonization and Standardization of Expanded Newborn Screening Results by Optimization of the Legacy Flow Injection Analysis Tandem Mass Spectrometry Methods and Application of a Standardiz	9
Utility of Epstein–Barr Virus DNA in Nasopharynx Swabs as a Reflex Test to Triage Seropositive Individuals in Nasopharyngeal Carcinoma Screening Programs	9
Average of Patient Deltas: Patient-Based Quality Control Utilizing the Mean Within-Patient Analyte Variation	9
Circulating Concentrations of C-Type Natriuretic Peptides Increase with Sacubitril/Valsartan Treatment in Healthy Young Men	9
Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking	9
Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results	9
Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus	9
Nonfasting Lipids for All Patients?	9
Applications of Digital Microscopy and Densely Connected Convolutional Neural Networks for Automated Quantification of Babesia-Infected Erythrocytes	9
Optimized Sequencing Adaptors Enable Rapid and Real-Time Metagenomic Identification of Pathogens during Runtime of Sequencing	9
Peripheral and Portal VenousKRASctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma	9
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets	9
Galaxy Is a Suitable Bioinformatics Platform for the Molecular Diagnosis of Human Genetic Disorders Using High-Throughput Sequencing Data Analysis: Five Years of Experience in a Clinical Laboratory	9
Association of Plasma Leucine-Rich Alpha-2 Glycoprotein 1 (LRG1) with All-Cause and Cause-Specific Mortality in Individuals with Type 2 Diabetes	8
Analytical and Clinical Performance of a Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Gastrin Subtypes G34 and G17 in Serum	8
CRISPR Cas9-Mediated Selective Isothermal Amplification for Sensitive Detection of Rare Mutant Alleles	8
Combining First and Second-Tier Newborn Screening in a Single Assay Using High-Throughput Chip-Based Capillary Electrophoresis Coupled to High-Resolution Mass Spectrometry	8
Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes	8
Predictive Performance of Cell-Free Nucleic Acid-Based Multi-Cancer Early Detection Tests: A Systematic Review	8
Rh Blood Group D Antigen Genotyping Using a Portable Nanopore-based Sequencing Device: Proof of Principle	8
Liquid Biopsy and Immuno-Oncology for Advanced Nonsmall Cell Lung Cancer	8
Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype	8
Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms	8
The Inflammation Biomarker GlycA Reflects Plasma N-Glycan Branching	8
LDL-Cholesterol versus Glucose in Microvascular and Macrovascular Disease	8
Circulating Cell-Free Mitochondrial DNA in Cerebrospinal Fluid as a Biomarker for Mitochondrial Diseases	8
Cardiovascular Disease in Women: Understanding the Journey	8
Challenges in Translating Clinical Metabolomics Data Sets from the Bench to the Bedside	8
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection	8
Development and Validation of Measurement Traceability for In Situ Immunoassays	8
Recent Developments in Mutation Enrichment and Detection Technologies	8
Towards a New Qualitative Screening Assay for Synthetic Cannabinoids Using Metabolomics and Machine Learning	7
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination	7
Personalized and Population-Based Reference Intervals for 48 Common Clinical Chemistry and Hematology Measurands: A Comparative Study	7
UMIErrorCorrect and UMIAnalyzer: Software for Consensus Read Generation, Error Correction, and Visualization Using Unique Molecular Identifiers	7
Sex-Specific 99th Percentile URLs for Cardiac Troponin Assays—Their Time Has Come	7
Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin	7
Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples	7
Mechanisms of Myocardial Injury in COVID-19	7
Diagnostic Host Gene Expression Analysis by Quantitative Reverse Transcription Loop-Mediated Isothermal Amplification to Discriminate between Bacterial and Viral Infections	7
The Vitamin D Metabolite Ratio (VMR) is a Biomarker of Vitamin D Status That is Not Affected by Acute Changes in Vitamin D Binding Protein	7
Practical Details for the Detection and Interpretation of Cryoglobulins	7
Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests	7
Assessing the Quality of Metagenomic Next-Generation Sequencing for Pathogen Detection in Lower Respiratory Infections	7
Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification	7
0/2 h-Algorithm for Rapid Triage of Suspected Myocardial Infarction Using a Novel High-Sensitivity Cardiac Troponin I Assay	7
Multiplexed Assay to Quantify the PP-Fold Family of Peptides in Human Plasma Using Microflow Liquid Chromatography–Tandem Mass Spectrometry	7
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma	7
New Equations for Estimating Glomerular Filtration Rate	7
Limitations of Accelerated Stability Model Based on the Arrhenius Equation for Shelf Life Estimation of In Vitro Diagnostic Products	7
Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study	7
Identification of Optimal Urinary Biomarkers of Synthetic Cannabinoids BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID, and BZO-CHMOXIZID for Illicit Abuse Monitoring	7
Alternative Sample Matrices Supporting Remote Sample Collection during the Pandemic and Beyond	7
Long-Read Sequencing with Hierarchical Clustering for Antiretroviral Resistance Profiling of Mixed Human Immunodeficiency Virus Quasispecies	7
Liquid Biopsy Hotspot Variant Assays: Analytical Validation for Application in Residual Disease Detection and Treatment Monitoring	7
High-Sensitivity Cardiac Troponin I and T Kinetics Differ following Coronary Bypass Surgery: A Systematic Review and Meta-Analysis	7
Evolution of Blood Sample Transportation and Monitoring Technologies	7
Sex Hormones and Adrenal Steroids: Biological Variation Estimated Using Direct and Indirect Methods	7
Measurement Biases Distort Cell-Free DNA Fragmentation Profiles and Define the Sensitivity of Metagenomic Cell-Free DNA Sequencing Assays	6
Parallel Analysis of Pre- and Postoperative Circulating Tumor DNA and Matched Tumor Tissues in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Cohort Study	6
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients	6
Microbiome-Derived Liquid Biopsy: New Hope for Cancer Screening?	6